Your browser doesn't support javascript.
loading
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma.
Leypoldt, Lisa B; Tichy, Diana; Besemer, Britta; Hänel, Mathias; Raab, Marc S; Mann, Christoph; Munder, Markus; Reinhardt, Hans Christian; Nogai, Axel; Görner, Martin; Ko, Yon-Dschun; de Wit, Maike; Salwender, Hans; Scheid, Christof; Graeven, Ullrich; Peceny, Rudolf; Staib, Peter; Dieing, Annette; Einsele, Hermann; Jauch, Anna; Hundemer, Michael; Zago, Manola; Pozek, Ema; Benner, Axel; Bokemeyer, Carsten; Goldschmidt, Hartmut; Weisel, Katja C.
Afiliação
  • Leypoldt LB; Department of Hematology, Oncology and Bone Marrow Transplantation With Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tichy D; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.
  • Besemer B; Department of Hematology, Oncology, Immunology and Rheumatology, University Hospital of Tuebingen, Tuebingen, Germany.
  • Hänel M; Department of Hematology, Oncology and Bone Marrow Transplantation, Klinikum Chemnitz, Chemnitz, Germany.
  • Raab MS; Internal Medicine V and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Mann C; Department of Hematology, Oncology and Immunology, University Hospital of Gießen and Marburg, Marburg, Germany.
  • Munder M; Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany.
  • Reinhardt HC; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, German Cancer Consortium (DKTK partner site Essen), Essen, Germany.
  • Nogai A; Department of Internal Medicine, Charité-University Medicine Berlin, Berlin, Germany.
  • Görner M; Department of Hematology, Oncology and Palliative Care, Klinikum Bielefeld Mitte, Bielefeld, Germany.
  • Ko YD; Department of Internal Medicine, Hematology and Oncology, Johanniter Krankenhaus Bonn, Bonn, Germany.
  • de Wit M; Department of Internal Medicine, Hematology, Oncology and Palliative Medicine, Vivantes Klinikum Neukölln, Berlin, Germany.
  • Salwender H; Asklepios Tumorzentrum Hamburg, AK Altona and AK St Georg, Hamburg, Germany.
  • Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
  • Graeven U; Department of Hematology, Oncology and Gastroenterology, Kliniken Maria Hilf, Mönchengladbach, Germany.
  • Peceny R; Department of Oncology, Hematology and Stem Cell Transplantation, Klinikum Osnabrück, Osnabrück, Germany.
  • Staib P; Department of Hematology and Oncology, St Antonius Hospital Eschweiler, Eschweiler, Germany.
  • Dieing A; Department of Hematology and Oncology, Vivantes Klinikum am Urban, Berlin, Germany.
  • Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Jauch A; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
  • Hundemer M; Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Zago M; Center for Clinical Trials, University Hospital of Tuebingen, Tuebingen, Germany.
  • Pozek E; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.
  • Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.
  • Bokemeyer C; Department of Hematology, Oncology and Bone Marrow Transplantation With Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Goldschmidt H; Internal Medicine V, GMMG-Studygroup at University Hospital Heidelberg, Heidelberg, Germany.
  • Weisel KC; Department of Hematology, Oncology and Bone Marrow Transplantation With Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
J Clin Oncol ; 42(1): 26-37, 2024 Jan 01.
Article em En | MEDLINE | ID: mdl-37753960
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha